125742 S1 M2 27 literature references

Pfizer Documents (PHMPT/FDA)

Pfizer Bla Submission

Pfizer 16 Plus Documents

2

Download PDF ↗ Live URL (may be dead)

Document text

BNT162b2
2.7.5Literature References
CONFIDENTIAL
Page 12.7.5  LITERATURE REFERENCE S
References are listed in the clinical summary  documents as indicated below:
Module 2.7.1 Summary  of Biopharmaceutic Studies and Associated Anal ytical 
Methods -None
Module 2.7.2 Summary  of Clinical Pharmacology  Studies -Not Applicable
Module 2.7.3 Summary  of Clinical Efficacy , References
Module 2.7.4 Summary  of Clinical Safety , References
Copies of the literature references are provided in Module 5.4 L iterature References.
090177e195aa9652\Approved\Approved On: 01-Dec-2020 23:58 (GMT)
FDA-CBER-2021-5683-0013921
Document Approval Record
Document Name: 		 

  		   
Document Title: 		 

  		   
Signed By: Date(GMT) Signing Capacity
 !"# 			 $%&%	 '( )**"+(
090177e195aa9652\Approved\Approved On: 01-Dec-2020 23:58 (GMT)
FDA-CBER-2021-5683-0013922